POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 56 filers reported holding POINT BIOPHARMA GLOBAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $231,339 | -56.5% | 31,821 | -56.4% | 0.13% | -52.6% |
Q4 2022 | $532,031 | +9.0% | 72,981 | +15.5% | 0.27% | +54.7% |
Q3 2022 | $488,000 | +559.5% | 63,169 | +485.3% | 0.17% | +437.5% |
Q2 2022 | $74,000 | -84.6% | 10,793 | -82.0% | 0.03% | -85.7% |
Q1 2022 | $479,000 | +399.0% | 60,103 | +251.6% | 0.22% | +1300.0% |
Q4 2021 | $96,000 | – | 17,096 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 2,312,523 | $18,431,000 | 4.36% |
GREAT POINT PARTNERS LLC | 2,060,000 | $16,418,000 | 3.97% |
RA Capital Management | 9,003,018 | $71,754,000 | 1.57% |
JOHNSON & JOHNSON | 1,000,000 | $7,970,000 | 1.51% |
BVF INC/IL | 3,367,826 | $26,842,000 | 1.07% |
Boxer Capital, LLC | 2,500,000 | $19,925,000 | 1.02% |
Sio Capital Management, LLC | 377,684 | $3,010,000 | 1.00% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,014,408 | $24,025,000 | 0.73% |
SILVERARC CAPITAL MANAGEMENT, LLC | 204,679 | $1,631,000 | 0.68% |
Atom Investors LP | 60,103 | $479,000 | 0.22% |